Ganga Pharmaceuticals Ltd
GANGAPHARMBSE
₹12.50▲ +0.00 (+0.00%)
Mkt cap₹7 Cr
P/E73.53
Volume16.0K
Day range12.5 – 12.5
52W range9.35 – 13.97
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Last traded ₹12.50 on 8 Sept 2026 (51 days ago). Not a live price.
Ganga Pharmaceuticals Ltd (GANGAPHARM): company summary
Ganga Pharmaceuticals Ltd (GANGAPHARM) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.
Ganga Pharmaceuticals Ltd (GANGAPHARM) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Ganga Pharmaceuticals Ltd last traded at ₹12.5, unchanged on the day.
- Financial performance
- Revenue has been growing steadily at 4.6% a year over three years; profit grew 35.7% a year, ahead of revenue — margins are expanding. Return on equity is 1.2%.
- Valuation multiples
- The stock trades at 73.5 times earnings, a premium to the Healthcare median of 32.0, 0.89 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
52W₹9.35
₹13.97
Key numbers
Price-based figures are live; statement figures are from FY26, consolidated where filed.
Valuation
- Market cap
- ₹7 Cr
- P/E
- 73.5×
- P/B
- 0.9×
- P/S
- —
- EV/EBITDA
- —
- Earnings yield
- 1.4%
- Dividend yield
- 0.00%
- Fair value
Profitability
- ROE
- 1.2%
- ROCE
- 2.8%
- ROIC
- 2.2%
- ROA
- 1.1%
- Gross margin
- 53.9%
- Operating margin
- 1.4%
- Net margin
- 3.6%
- EPS (TTM/FY)
- ₹0.17
Growth
- Sales · last qtr YoY
- —
- Profit · last qtr YoY
- —
- Sales · 1Y
- +7.2%
- Profit · 1Y
- +25.0%
- Sales CAGR · 3Y / 5Y
- +5% / +5%
- Profit CAGR · 3Y / 5Y
- +36% / +38%
- EPS CAGR · 5Y
- +28%
- Sales CAGR · 10Y
- +1%
Balance sheet
- Debt / equity
- 0.13
- Net debt / EBITDA
- 26.39×
- Interest cover
- 2.0×
- Current ratio
- 6.12
- Total debt
- ₹1 Cr
- Cash
- ₹0 Cr
- Book value / share
- ₹14.1
- Free cash flow
- −₹1 Cr
Quality & trading
- Piotroski F-score
- 4 / 9
- Altman Z
- 8.19
- Cash conversion cycle
- 423 days
- Dividend payout
- 0%
- Delivery %
- 100.0%
- Volume vs 30D avg
- —
- Avg traded value
- —
- Face value
- ₹10.00
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Ganga Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Ganga Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LDR. REDDY S LABORATORIESCIPLA LTDMANKIND PHARMA LIMITEDAUROBINDO PHARMA LTDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Ganga Pharmaceuticals Ltd with peers
Ganga Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND LGanga Pharmaceuticals Ltd vs DIVI S LABORATORIES LTDGanga Pharmaceuticals Ltd vs TORRENT PHARMACEUTICALS LGanga Pharmaceuticals Ltd vs LAURUS LABS LIMITEDGanga Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTDGanga Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. L
Related tools & concepts
Value Ganga Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing